中国原创临床研究速递
Updates of Original Clinical Trials of Valvular Heart Disease from China
04/17 12:20-13:20
上海厅 (Room Shanghai)
-
12:20-13:20
-
12:20-13:20
-
12:20-12:30对比单把与双把缝合器用于闭合TAVR血管入路的多中心、随机对照研究：Single-Closure研究Single-Closure Study: A Multicenter, Randomized Controlled Trial Comparing Single- vs. Dual-Proclosure Suture-Mediated Closure Devices for Vascular Access Site Hemostasis After Transcatheter Aortic Valve Replacement
-
12:30-12:40TAVR术后单药抗血小板与抗凝的多中心、随机对照研究：TAORTA研究TAORTA Study: A Multicenter, Randomized Controlled Trial of Single Antiplatelet Therapy Versus Anticoagulation Following Transcatheter Aortic Valve Replacement
-
12:40-12:50TEER治疗二尖瓣反流交界区病变的多中心、随机对照研究：TEER-CD研究TEER-CD Study: A Multicenter, Randomized Controlled Trial of Transcatheter Edge-to-Edge Repair for the Treatment of Commissural Mitral Regurgitation
-
12:50-13:00经颈静脉LuX瓣膜用于治疗三尖瓣关闭不全的多中心、随机对照研究：TRAVEL研究TRAVEL Study: A Multicenter, Randomized Controlled Trial of the Transjugular LuX-Valve for the Treatment of Tricuspid Regurgitation
-
13:00-13:10NXT-DURA研究——首款非醛交联干瓣TaurusNXT-2年随访结果NXT-DURA Study: Two-Year Follow-Up Results of the TaurusNXT Valve—The First Non-Aldehyde Crosslinked, Dry Tissue Valve